TY - JOUR AU - Jamie Jarboe AU - Muhammad Saif PY - 2013/07/10 Y2 - 2024/03/28 TI - First Line Therapy for Metastatic Pancreatic Cancer JF - JOP. Journal of the Pancreas JA - JOP VL - 14 IS - 4 SE - Highlights from the “2013 ASCO Annual Meeting”. Chicago, IL, USA. May 31 - June 4, 2013 DO - 10.6092/1590-8577/1667 UR - http://www.serena.unina.it/index.php/jop/article/view/1667 AB - Metastatic pancreatic cancer remains a difficult disease to treat; however, there are more new drug combinations on the horizon each week. We will discuss the results of the MPACT trial presented at the 2013 ASCO Annual Meeting (Abstracts #4005, #4058, and #4059) and compare to the 2011 FOLFIRINOX data.Image: MPACT control and experimental arms. ER -